RIFAPENTINE
Plans to restrict open market access to tuberculosis medicinesIndia is tightening access to anti-TB drugs Bedaquiline and Delamanid due to rising drug-resistant tuberculosis cases and potential misuse ...
Regulator waives off clinical trials, clears Sanofi TB Drug“We have recently received final approval for rifapentine from the Indian regulatory authorities. Rifapentine is now officially registered ...
Regulator waives off clinical trials, clears Sanofi TB drugIndia carries the highest burden of TB with about 2.69 mn cases in 2018. About 40% of the country’s population is estimated to have latent ...
Sanofi inks pact with Unitaid; to reduce TB drug Rifapentine price by 70%In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to...
Load More